Post by Courtney Rice

Biotech Commercialization | Rare Disease | Specialty Payer Marketing

Good news for Huntington's and UniQure. UniQure will submit a BLA in Q326 for accelerated approval of its gene therapy AMT-130. This is big news. No drug is without its controversies but this community needs hope and Accelerated Approval is the right pathway to grant access while building data. https://lnkd.in/efrytwak

Post content